4.7 Review

Ethnicity Influences Phenotype and Outcomes in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis of Population-based Studies

Journal

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
Volume 16, Issue 2, Pages 190-+

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.cgh.2017.05.047

Keywords

Crohn's Disease; Ulcerative Colitis; Ethnicity; Behavior; Race; Surgery

Funding

  1. US National Institutes of Health [K23 DK097142]
  2. Merck
  3. Amgen
  4. AbbVie
  5. Ferring
  6. Janssen
  7. Takeda
  8. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, K23DK097142] Funding Source: NIH RePORTER

Ask authors/readers for more resources

BACKGROUND & AIMS: Inflammatory bowel diseases (IBDs) (Crohn's disease [CD], ulcerative colitis) are global diseases. Similarities and differences in disease presentation and outcomes across different geographic regions and ethnic groups have not been compared previously. METHODS: We performed a systematic review and meta-analysis of population-based cohort studies examining the phenotype and outcome of IBD across ethnic groups categorized as Whites, Blacks, Hispanics, and Asians. Further stratification was performed by migration status (native or immigrant). Pooled proportions of disease location, behavior, medication, and surgery use were calculated by using a random-effects model and compared statistically. RESULTS: Our final analysis included 198 unique studies reporting outcomes on 525,425 IBD patients (Caucasian, 65%; Asian, 30%; Hispanic, 2%; and Black, 1%). CD in Asians but not other ethnicities demonstrated a strong male predominance. Family history of IBD was infrequent in Asian patients. Both Black and Asian CD patients demonstrated perianal involvement more frequently. Surgery for both CD and UC was less common in Asians than Caucasians. Compared with native residents, a family history of IBD was reported more often among immigrant IBD patients, but no significant differences were noted in phenotype. CONCLUSIONS: We demonstrate significant variation in the demographic distribution, familial predisposition, phenotype, and outcomes of IBD between Caucasians, Blacks, Hispanics, and Asians. There is need for further study to understand the biology behind this variation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Gastroenterology & Hepatology

Risks of post-colonoscopic polypectomy bleeding and thromboembolism with warfarin and direct oral anticoagulants: a population-based analysis

Louis H. S. Lau, Cosmos L. T. Guo, Terry C. F. Yip, Joyce W. Y. Mak, Sunny H. Wong, Kelvin L. Y. Lam, Grace L. H. Wong, Siew C. Ng, Francis K. L. Chan

Summary: The study found that apixaban had a significantly lower risk of PPB and thromboembolism compared to warfarin, dabigatran, and rivaroxaban, especially in older patients with right-sided polyps.
Article Gastroenterology & Hepatology

Microbiota engraftment after faecal microbiota transplantation in obese subjects with type 2 diabetes: a 24-week, double-blind, randomised controlled trial

Siew C. Ng, Zhilu Xu, Joyce Wing Yan Mak, Keli Yang, Qin Liu, Tao Zuo, Whitney Tang, Louis Lau, Rashid N. Lui, Sunny H. Wong, Yee Kit Tse, Amy Y. L. Li, Kitty Cheung, Jessica Y. L. Ching, Vincent W. S. Wong, Alice P. S. Kong, Ronald C. W. Ma, Elaine Y. K. Chow, Simon K. H. Wong, Ivan Chak Hang Ho, Paul K. S. Chan, Francis K. L. Chan

Summary: Repeated FMTs enhance microbiota engraftment in obese patients with T2DM, leading to more favorable changes in recipients' microbiota and improvement in lipid profile and liver stiffness when combined with lifestyle intervention.
Article Gastroenterology & Hepatology

Lactobacillus gallinarum modulates the gut microbiota and produces anti-cancer metabolites to protect against colorectal tumourigenesis

Naoki Sugimura, Qing Li, Eagle Siu Hong Chu, Harry Cheuk Hay Lau, Winnie Fong, Weixin Liu, Cong Liang, Geicho Nakatsu, Anthony Chin Yang Su, Olabisi Oluwabukola Coker, William Ka Kei Wu, Francis Ka Leung Chan, Jun Yu

Summary: In this study, we found that L. gallinarum significantly reduced intestinal tumor number and size in murine models, by producing protective metabolites that promote apoptosis of colorectal cancer cells, thus protecting against intestinal tumorigenesis.
Article Gastroenterology & Hepatology

Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome

Qin Liu, Joyce Wing Yan Mak, Qi Su, Yun Kit Yeoh, Grace Chung-Yan Lui, Susanna So Shan Ng, Fen Zhang, Amy Y. L. Li, Wenqi Lu, David Shu-Cheong Hui, Paul K. S. Chan, Francis K. L. Chan, Siew C. Ng

Summary: This study investigated the link between gut microbiome composition and post-acute COVID-19 syndrome. The results showed that the gut microbiome of patients with long-term complications of COVID-19 differed significantly from that of non-COVID-19 controls and patients without post-acute COVID-19 syndrome.
Letter Gastroenterology & Hepatology

Modulation of gut microbiota impacts diet-induced and drug-induced alopecia in mice

Siu Lam, Jingwan Zhang, Keli Yang, Lok Cheung Chu, Wenyi Zhu, Whitney Tang, Francis K. L. Chan, Paul K. S. Chan, William K. K. Wu, Siew C. Ng

Article Gastroenterology & Hepatology

Gut microbiota composition is associated with SARS-CoV-2 vaccine immunogenicity and adverse events

Siew C. Ng, Ye Peng, Lin Zhang, Chris Kp Mok, Shilin Zhao, Amy Li, Jessica Y. L. Ching, Yingzhi Liu, Shuai Yan, Dream L. S. Chan, Jie Zhu, Chunke Chen, Adrian C. H. Fung, Kenneth K. Y. Wong, David S. C. Hui, Francis K. L. Chan, Hein M. Tun

Summary: This study identified specific gut microbiota markers associated with improved immune response and reduced adverse events following COVID-19 vaccines, suggesting that microbiota-targeted interventions may complement the effectiveness of vaccines.
Article Gastroenterology & Hepatology

Gut microbiota-derived synbiotic formula (SIM01) as a novel adjuvant therapy for COVID-19: An open-label pilot study

Lin Zhang, Zhilu Xu, Joyce W. Y. Mak, Kai Ming Chow, Grace Lui, Timothy C. M. Li, Chun Kwok Wong, Paul K. S. Chan, Jessica Y. L. Ching, Yasuhiro Fujiwara, Francis K. L. Chan, Siew C. Ng

Summary: This study demonstrated that hospitalized COVID-19 patients receiving a novel gut microbiota-derived synbiotic formula (SIM01) as an adjuvant therapy showed accelerated antibody formation against SARS-CoV-2, reduced nasopharyngeal viral load, decreased pro-inflammatory immune markers, and restored gut dysbiosis.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2022)

Correction Medicine, Research & Experimental

Epigenomic characterization of a p53-regulated 3p22.2 tumor suppressor that inhibits STAT3 phosphorylation via protein docking and is frequently methylated in esophageal and other carcinomas (vol 8, pg 61, 2018)

Lili Li, Juan Xu, Guohua Qiu, Jianming Ying, Zhenfang Du, Tingxiu Xiang, Kai Yau Wong, Gopesh Srivastava, Xiao-Feng Zhu, Tony S. Mok, Anthony T. C. Chan, Francis K. L. Chan, Richard F. Ambinder, Qian Tao

THERANOSTICS (2022)

Letter Gastroenterology & Hepatology

Post-acute COVID-19 syndrome and gut dysbiosis linger beyond 1 year after SARS-CoV-2 clearance

Qi Su, Raphaela Iris Lau, Qin Liu, Francis Ka Leung Chan, Siew Chien Ng

Article Cell Biology

A Probiotic Formula for Modulation of Colorectal Cancer Risk via Reducing CRC-Associated Bacteria

Jessie Qiaoyi Liang, Yao Zeng, Effie Yin Tung Lau, Yuting Sun, Yao Huang, Tingyu Zhou, Zhilu Xu, Jun Yu, Siew Chien Ng, Francis Ka Leung Chan

Summary: A newly developed probiotic formula was found to modulate the dysbiosis of gut microbiota associated with colorectal cancer by inhibiting the growth of pathogenic bacteria.

CELLS (2023)

Meeting Abstract Gastroenterology & Hepatology

ANTI-OBESITY AND LIPID-LOWERING EFFECTS OF A COMMENSAL BACTERIUM RX AND ITS METABOLITES

Wenyi Zhu, Jingwan Zhang, Wenli Huang, Zhilu Xu, Wenqi Lu, Hui Zhan, Qianru Sun, Francis K. Chan, William K. Wu, Siew C. Ng

GASTROENTEROLOGY (2022)

Meeting Abstract Gastroenterology & Hepatology

CARDIOVASCULAR DISEASE RISK IS REFLECTED IN DISTINCT GUT MICROBIOTA SIGNATURES IN ASYMPTOMATIC INDIVIDUALS

Lawrence Y. Ip, Yun Kit Yeoh, Chun Pan Cheung, Anki Miu, Bonaventure Y. Ip, Francis K. Chan, Thomas W. Leung, Siew C. Ng

GASTROENTEROLOGY (2022)

Meeting Abstract Gastroenterology & Hepatology

A PROBIOTIC FORMULA (SMT04) FOR MODULATION OF COLORECTAL CANCER RISK VIA REDUCING CRC-ASSOCIATED BACTERIAL GENE MARKERS

Jessie Qiaoyi Liang, Yao Zeng, Zhi Lu Xu, Siew C. Ng, Francis K. Chan

GASTROENTEROLOGY (2022)

Meeting Abstract Gastroenterology & Hepatology

META-ANALYSIS OF GUT MICROBIOME STUDIES IDENTIFIES CONSISTENT OBESITY-SPECIFIC MICROBIAL SIGNATURES AND SHARED METABOLIC PATHWAYS

Yu Lin, Zhilu Xu, Yun Kit Yeoh, Wenli Huang, Wei Jiang, Francis K. Chan, Siew C. Ng

GASTROENTEROLOGY (2022)

No Data Available